Halofuginone ameliorates systemic lupus erythematosus by targeting Blk in myeloid-derived suppressor cells.
Int Immunopharmacol
; 114: 109487, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36493694
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myeloid-Derived Suppressor Cells
/
Lupus Erythematosus, Systemic
Limits:
Animals
Language:
En
Journal:
Int Immunopharmacol
Journal subject:
ALERGIA E IMUNOLOGIA
/
FARMACOLOGIA
Year:
2023
Document type:
Article
Country of publication:
Países Bajos